|
|
|
Volumn 10, Issue 2, 1999, Pages 99-101
|
|
Hepatitis B vaccines: Why does doing good have its opponents? - Editorial
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HEPATITIS B VACCINE;
CANADA;
DEMYELINATING DISEASE;
DRUG COST;
DRUG INFORMATION;
DRUG SAFETY;
EDITORIAL;
FRANCE;
HEALTH PROGRAM;
HEPATITIS B;
HIGH RISK POPULATION;
HUMAN;
INFECTION CONTROL;
MULTIPLE SCLEROSIS;
PATIENT COUNSELING;
RISK BENEFIT ANALYSIS;
SCHOOL HEALTH SERVICE;
UNITED STATES;
VACCINATION;
WORLD HEALTH ORGANIZATION;
|
|
EID: 0032913970
PISSN: 11802332
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (1)
|
|
References (1)
|
